Potential dangers of direct-to-consumer genetic test for cancer risk

  • Post author:
  • Post category:uncategorized

A new editorial was published in Oncotarget’s Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests.”